Kosnopfel C, Sinnberg T, Sauer B, et al. MAPK inhibitor resistant melanoma cells can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. SMR 2017, abstract P01-9.
Fulvestrant plus anastrozol bij gemetastaseerd mammacarcinoom: langetermijnresultaten
jun 2019 | Borstkanker